
GMReis received FDA 510(k) clearance to market the complete FASTLOCK line—knotless, tape-loaded anchors designed for ligament augmentation in the foot, ankle, knee, shoulder, and hip.
This achievement expands the company’s Sports Medicine portfolio, bringing FDA-cleared solutions developed to deliver precision, strength, and versatility in soft tissue fixation.
Source: GMReis
GMReis received FDA 510(k) clearance to market the complete FASTLOCK line—knotless, tape-loaded anchors designed for ligament augmentation in the foot, ankle, knee, shoulder, and hip.
This achievement expands the company’s Sports Medicine...
GMReis received FDA 510(k) clearance to market the complete FASTLOCK line—knotless, tape-loaded anchors designed for ligament augmentation in the foot, ankle, knee, shoulder, and hip.
This achievement expands the company’s Sports Medicine portfolio, bringing FDA-cleared solutions developed to deliver precision, strength, and versatility in soft tissue fixation.
Source: GMReis
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





